Return On Equity in % of Galera Therapeutics, Inc. from 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Galera Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from 2018 to Q3 2025.
  • Galera Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was 6.07 %, a 57.7% decline year-over-year.
  • Galera Therapeutics, Inc. annual Return On Equity for 2024 was 13.5 %, a 73.2% decline from 2023.
  • Galera Therapeutics, Inc. annual Return On Equity for 2023 was 50.3 %, a 27.2% decline from 2022.
  • Galera Therapeutics, Inc. annual Return On Equity for 2022 was 69.1 %, a 70.6% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Galera Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 6.07 -8.28 -57.7% 01 Jul 2025 30 Sep 2025
Q2 2025 8.99 -13 -59.1% 01 Apr 2025 30 Jun 2025
Q1 2025 11.2 -24.9 -68.9% 01 Jan 2025 31 Mar 2025
Q4 2024 13.5 -36.8 -73.2% 01 Oct 2024 31 Dec 2024
Q3 2024 14.3 -47.8 -76.9% 01 Jul 2024 30 Sep 2024
Q2 2024 22 -45.5 -67.4% 01 Apr 2024 30 Jun 2024
Q1 2024 36.1 -30.5 -45.8% 01 Jan 2024 31 Mar 2024
Q4 2023 50.3 -18.8 -27.2% 01 Oct 2023 31 Dec 2023
Q3 2023 62.2 -19.1 -23.5% 01 Jul 2023 30 Sep 2023
Q2 2023 67.4 -41.6 -38.2% 01 Apr 2023 30 Jun 2023
Q1 2023 66.6 -90.2 -57.5% 01 Jan 2023 31 Mar 2023
Q4 2022 69.1 -166 -70.6% 01 Oct 2022 31 Dec 2022
Q3 2022 81.3 -377 -82.3% 01 Jul 2022 30 Sep 2022
Q2 2022 109 -5.82K -98.2% 01 Apr 2022 30 Jun 2022
Q1 2022 157 +650 01 Jan 2022 31 Mar 2022
Q4 2021 235 +474 01 Oct 2021 31 Dec 2021
Q3 2021 458 +609 01 Jul 2021 30 Sep 2021
Q2 2021 5.93K +7.4K 01 Apr 2021 30 Jun 2021
Q1 2021 -493 -651 -411% 01 Jan 2021 31 Mar 2021
Q4 2020 -239 -304 -470% 01 Oct 2020 31 Dec 2020
Q3 2020 -151 -186 -527% 01 Jul 2020 30 Sep 2020
Q2 2020 -1.47K -1.5K -4678% 01 Apr 2020 30 Jun 2020
Q1 2020 158 +130 +461% 01 Jan 2020 31 Mar 2020
Q4 2019 64.6 +39 +152% 01 Oct 2019 31 Dec 2019
Q3 2019 35.4 01 Jul 2019 30 Sep 2019
Q2 2019 32.1 01 Apr 2019 30 Jun 2019
Q1 2019 28.2 01 Jan 2019 31 Mar 2019
Q4 2018 25.6 01 Oct 2018 31 Dec 2018

Galera Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 13.5 -36.8 -73.2% 01 Jan 2024 31 Dec 2024
2023 50.3 -18.8 -27.2% 01 Jan 2023 31 Dec 2023
2022 69.1 -166 -70.6% 01 Jan 2022 31 Dec 2022
2021 235 +474 01 Jan 2021 31 Dec 2021
2020 -239 -304 -470% 01 Jan 2020 31 Dec 2020
2019 64.6 +39 +152% 01 Jan 2019 31 Dec 2019
2018 25.6 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.